Matthew Herper and Damian Garde

BioTech

Winners and losers from Medicare’s list of drugs subject to price negotiation

On Tuesday morning, the Department of Health and Human Services unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation

Matthew Herper and Damian Garde August 29, 2023

BioTech

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by

Matthew Herper and Damian Garde July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Matthew Herper and Damian Garde

Winners and losers from Medicare’s list of drugs subject to price negotiation

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe